Search Results - Fazal, Mehdi

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer

    Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer by Robertson, John F.R., Cheung, Kwok-Leung, Noguchi, Shinzaburo, Shao, Zhimin, Degboe, Arnold, Lichfield, Jasmine, Thirlwell, Jackie, Fazal, Mehdi, Ellis, Matthew J.

    Published 2018
    Get full text
  2. 2
    Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

    Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial by Robertson, John F.R., Bondarenko, Igor M., Trishkina, Ekaterina, Dvorkin, Mikhail, Panasci, Lawrence, Manikhas, Alexey, Shparyk, Yaroslav, Cardona-Huerta, Servando, Cheung, Kwok-Leung, Philco-Salas, Manuel Jesus, Ruiz-Borrego, Manuel, Shao, Zhimin, Noguchi, Shinzaburo, Rowbottom, Jacqui, Stuart, Mary, Grinsted, Lynda M., Fazal, Mehdi, Ellis, Matthew J.

    Published 2017
    Get full text

Search Tools: